Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 8/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | APAF1 | O14727 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16668506 | 1.00 | SLC9A1 (0.67) | SLC9A1MAPTNPC1RAB9AP2RX7 | |
| SCHEMBL16668516 | 1.00 | SLC9A1 (0.67) | SLC9A1MAPTNPC1RAB9AP2RX7 | |
| SCHEMBL16522426 | 0.87 | SLC9A1 (0.69) | SLC9A1MAPTNPC1RAB9AP2RX7 | |
| SCHEMBL10248342 | 0.82 | SLC9A1 (0.69) | SLC9A1MAPTNPC1RAB9AP2RX7 | |
| SCHEMBL18723133 | 0.81 | SLC9A1 (0.81) | SLC9A1MAPTNPC1RAB9AP2RX7 | |
| SCHEMBL18723216 | 0.81 | SLC9A1 (0.81) | SLC9A1MAPTNPC1RAB9AP2RX7 | |
| SCHEMBL461412 | 0.80 | SLC9A1 (1.00) | SLC9A1MAPTNPC1RAB9AP2RX7 | |
| SCHEMBL8633983 | 0.80 | SLC9A1 (1.00) | SLC9A1MAPTNPC1RAB9AP2RX7 | |
| SCHEMBL21052131 | 0.80 | SLC9A1 (0.71) | SLC9A1MAPTNPC1RAB9AP2RX7 | |
| SCHEMBL8406882 | 0.80 | SLC9A1 (1.00) | SLC9A1MAPTNPC1RAB9AP2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10676829-B2 | Corrosion inhibition composition for pipelines, process of elaboration and synthesis | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2020-06-09 | — | — | US | disclosed |
| US-20180265991-A1 | CORROSION INHIBITION COMPOSITION FOR PIPELINES, PROCESS OF ELABORATION AND SYNTHESIS | MEXICANO INST PETROL (MX) | 2018-09-20 | — | — | US | disclosed |
| US-10011908-B2 | Corrosion inhibition composition for pipelines, process of elaboration and synthesis | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2018-07-03 | — | — | US | disclosed |
| US-20150118104-A1 | CORROSION INHIBITION COMPOSITION FOR PIPELINES, PROCESS OF ELABORATION AND SYNTHESIS | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2015-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10676829-B2 | Corrosion inhibition composition for pipelines, process of elaboration and synthesis | TFPI, TBK1, JAK1 | SLC9A1 785/4885MAPT 984/4885NPC1 3788/4885 |
| US-20180265991-A1 | CORROSION INHIBITION COMPOSITION FOR PIPELINES, PROCESS OF ELABORATION AND SYNTHESIS | TFPI, TBK1, JAK1 | SLC9A1 785/4885MAPT 984/4885NPC1 3788/4885 |
| US-10011908-B2 | Corrosion inhibition composition for pipelines, process of elaboration and synthesis | TFPI, TBK1, JAK1 | SLC9A1 785/4885MAPT 984/4885NPC1 3788/4885 |
| US-20150118104-A1 | CORROSION INHIBITION COMPOSITION FOR PIPELINES, PROCESS OF ELABORATION AND SYNTHESIS | TFPI, TBK1, JAK1 | SLC9A1 785/4885MAPT 984/4885NPC1 3788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.